Market Overview:
The global methotrexate drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cancer and autoimmune diseases, and the rising demand for effective treatment options. By type, the global methotrexate drugs market is segmented into 2.5mg/ml and 2mg/ml segments. The 2mg/ml segment is expected to account for a larger share of the global market than the 2.5mg/ml segment during the forecast period owing to its higher efficacy in treating various diseases such as cancer and autoimmune diseases. By application, the global methotrexate drugs market is divided into cancer, autoimmune diseases, and other applications segments.
Product Definition:
Methotrexate is a drug used to treat cancer, arthritis, and other diseases. It is important because it can help to prevent the growth of cancer cells, reduce inflammation, and improve joint function in people with arthritis.
2.5mg/ml:
Methotrexate is a drug that is used to treat cancer and arthritis. It works by damaging the cells that are responsible for causing pain. The most common side effects of methotrexate include skin rash, itching, hair loss, mouth sores, bone marrow suppression (reduced production of blood cells), liver damage and gastrointestinal disturbance among others.
The global methotrexate drugs market was valued at USD 1.8 billion in 2015.
2mg/ml:
2mg/ml is the concentration of methotrexate in oral solution and it's used as an anti-cancer drug. It works by causing cancer cell death. The oral solution contains 2 mg of methotrexate per ml, which is equivalent to 6 minims of actual medication.
Methotrexate (MTX) is a chemotherapy drug that interferes with the growth of cancer cells and stops them from reproducing.
Application Insights:
Cancer was the dominant application segment and accounted for over 75% of total market volume in 2017. The growing use of methotrexate in cancer treatment, particularly breast cancer, is one of the key factors driving this segment. Breast cancer is a major concern for many women as it accounts for around 40% to 50% cases globally. According to Breastcancer.org, around 5-10% of women develop invasive breast carcinoma every year which leads to death approximately 1-2%.
The rising prevalence coupled with availability of advanced drugs such as Kadcyla (Doxil) and Zomacton (Somatropin) are expected to drive demand from the cancer segment over the forecast period. Other applications include rheumatoid arthritis and psoriasis among others; however these conditions are not prominent enough to create separate segments on their own so they will be included under other applications category during forecasting period.
Regional Analysis:
North America dominated the global market in 2017, with a revenue share of over 39.0%. The presence of key players and well-established healthcare infrastructure are some factors accounting for its largest share. Furthermore, increasing R&D activities to develop new formulations and improve existing therapies is expected to drive the region’s growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income levels, improving economic conditions, expanding middle-class population base along with growing awareness about early diagnosis in emerging countries such as China and India. These factors are expected to contribute toward increased demand for methotrexate drugs in this region during the forecast period. Moreover, favorable government initiatives pertaining towards improved access & coverage are also likely boost regional product demand during 2018 - 2030 time frame.
Growth Factors:
- Increasing incidence of cancer: The global incidence of cancer is increasing at an alarming rate. This is expected to drive the demand for methotrexate drugs in the coming years.
- Rising awareness about methotrexate drugs: There is a growing awareness among people about the benefits of using methotrexate drugs for various medical conditions. This is likely to boost the demand for these drugs in the coming years.
- Growing use of methotrexate drugs in combination therapy: Methotrexate drugs are increasingly being used in combination with other therapies to achieve better results. This is likely to fuel the growth of this market in the near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Methotrexate Drugs Market Research Report
By Type
2.5mg/ml, 2mg/ml
By Application
Cancer, Autoimmune Diseases, Other
By Companies
Silvergate Pharmaceuticals, ...
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Methotrexate Drugs Market Report Segments:
The global Methotrexate Drugs market is segmented on the basis of:
Types
2.5mg/ml, 2mg/ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer, Autoimmune Diseases, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Silvergate Pharmaceuticals
- ...
Highlights of The Methotrexate Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2.5mg/ml
- 2mg/ml
- By Application:
- Cancer
- Autoimmune Diseases
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Methotrexate Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Methotrexate drugs are used to treat cancer. Methotrexate works by stopping the growth of cancer cells.
Some of the major companies in the methotrexate drugs market are Silvergate Pharmaceuticals.
The methotrexate drugs market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Methotrexate Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Methotrexate Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Methotrexate Drugs Market - Supply Chain
4.5. Global Methotrexate Drugs Market Forecast
4.5.1. Methotrexate Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Methotrexate Drugs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Methotrexate Drugs Market Absolute $ Opportunity
5. Global Methotrexate Drugs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Methotrexate Drugs Market Size and Volume Forecast by Type
5.3.1. 2.5mg/ml
5.3.2. 2mg/ml
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Methotrexate Drugs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Methotrexate Drugs Market Size and Volume Forecast by Application
6.3.1. Cancer
6.3.2. Autoimmune Diseases
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Methotrexate Drugs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Methotrexate Drugs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Methotrexate Drugs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Methotrexate Drugs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Methotrexate Drugs Demand Share Forecast, 2019-2029
9. North America Methotrexate Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Methotrexate Drugs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Methotrexate Drugs Market Size and Volume Forecast by Application
9.4.1. Cancer
9.4.2. Autoimmune Diseases
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Methotrexate Drugs Market Size and Volume Forecast by Type
9.7.1. 2.5mg/ml
9.7.2. 2mg/ml
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Methotrexate Drugs Demand Share Forecast, 2019-2029
10. Latin America Methotrexate Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Methotrexate Drugs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Methotrexate Drugs Market Size and Volume Forecast by Application
10.4.1. Cancer
10.4.2. Autoimmune Diseases
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Methotrexate Drugs Market Size and Volume Forecast by Type
10.7.1. 2.5mg/ml
10.7.2. 2mg/ml
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Methotrexate Drugs Demand Share Forecast, 2019-2029
11. Europe Methotrexate Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Methotrexate Drugs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Methotrexate Drugs Market Size and Volume Forecast by Application
11.4.1. Cancer
11.4.2. Autoimmune Diseases
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Methotrexate Drugs Market Size and Volume Forecast by Type
11.7.1. 2.5mg/ml
11.7.2. 2mg/ml
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Gowth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Methotrexate Drugs Demand Share, 2019-2029
12. Asia Pacific Methotrexate Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Methotrexate Drugs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Methotrexate Drugs Market Size and Volume Forecast by Application
12.4.1. Cancer
12.4.2. Autoimmune Diseases
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Methotrexate Drugs Market Size and Volume Forecast by Type
12.7.1. 2.5mg/ml
12.7.2. 2mg/ml
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Methotrexate Drugs Demand Share, 2019-2029
13. Middle East & Africa Methotrexate Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Methotrexate Drugs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Methotrexate Drugs Market Size and Volume Forecast by Application
13.4.1. Cancer
13.4.2. Autoimmune Diseases
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Methotrexate Drugs Market Size and Volume Forecast by Type
13.7.1. 2.5mg/ml
13.7.2. 2mg/ml
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Methotrexate Drugs Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Methotrexate Drugs Market: Market Share Analysis
14.2. Methotrexate Drugs Distributors and Customers
14.3. Methotrexate Drugs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Silvergate Pharmaceuticals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. ...
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. COMPANY3
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
